Benthic Genomics

Benthic Genomics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.8M

Overview

Benthic Genomics is a private, early-stage bioinformatics company founded in 2021 and based in Cambridge, Massachusetts. It has developed a proprietary software analysis platform that leverages an advanced, graph-based reference to deliver superior genotyping accuracy and resolution in complex immune genomic regions from multiple data types, including microarrays and NGS. The company appears to be pre-revenue, operating a platform business model focused on providing analytical tools to research and clinical labs. Its primary value proposition is enabling high-performance, cost-effective analysis of critical genomic regions that are traditionally difficult to characterize.

Genetics & Genomics

Technology Platform

Proprietary pan-immune reference graph and associated algorithms for high-resolution genotyping, phasing, and variant calling in complex genomic regions (HLA, KIR, pharmacogenes) from microarray, short-read, and long-read sequencing data.

Funding History

1
Total raised:$3.8M
Seed$3.8M

Opportunities

The large installed base of microarray systems represents a key market for cost-effective performance upgrades.
The growing fields of immunogenomics, cell therapy, and pharmacogenomics drive demand for high-resolution analysis of complex regions.
The platform's compatibility with multiple data types allows it to address a broad customer base.

Risk Factors

Commercialization risk in convincing labs to adopt a new platform over established methods.
Technological risk if independent validation does not support performance claims.
Competition from both academic tools and larger commercial bioinformatics companies.

Competitive Landscape

Competes with academic HLA/KIR typing tools (e.g., from NIH-funded projects) and broader bioinformatics suites from companies like Illumina, Qiagen, and DNAnexus. Its differentiation lies in its specialized, graph-based reference and focus on extracting maximum resolution from cost-effective data types like microarrays.